Abstract
In the tumor microenvironment, arginine is metabolized by arginase-expressing myeloid cells. This arginine depletion profoundly inhibits T cell functions and is crucially involved in tumor-induced immunosuppression. Reconstitution of adaptive immune functions in the context of arginase-mediated tumor immune escape is a promising therapeutic strategy to boost the immunological antitumor response. Arginine can be recycled in certain mammalian tissues from citrulline via argininosuccinate (ASA) in a two-step enzymatic process involving the enzymes argininosuccinate synthase (ASS) and argininosuccinate lyase (ASL). Here, we demonstrate that anti-CD3/anti-CD28-activated human primary CD4+ and CD8+ T cells upregulate ASS expression in response to low extracellular arginine concentrations, while ASL is expressed constitutively. ASS expression peaked under moderate arginine restriction (20 µM), but no relevant induction was detectable in the complete absence of extracellular arginine. The upregulated ASS correlated with a reconstitution of T cell proliferation upon supplementation of citrulline, while the suppressed production of IFN-γ was refractory to citrulline substitution. In contrast, ASA reconstituted proliferation and cytokine synthesis even in the complete absence of arginine. By direct quantification of intracellular metabolites we show that activated primary human T cells import citrulline but only metabolize it further to ASA and arginine when ASS is expressed in the context of low amounts of extracellular arginine. We then clarify that citrulline transport is largely mediated by the L-type amino acid transporter 1 (LAT1), induced upon human T cell activation. Upon siRNA-mediated knockdown of LAT1, activated T cells lost the ability to import citrulline. These data underline the potential of citrulline substitution as a promising pharmacological way to treat immunosuppression in settings of arginine deprivation.
Highlights
T lymphocyte activation relies on reprogramming of key metabolic pathways and the sufficient availability of nutrients like glucose and amino acids [1, 2]
We have recently shown that activated human T cells dramatically increase arginine import, due to the specific upregulation of cationic amino acid transporter-1 (CAT-1) [16], and that this induction of CAT-1 is necessary for efficient T cell proliferation [16]
In the complete absence of arginine, human T cell proliferation cannot be rescued by supplementation of citrulline [16, 23]
Summary
T lymphocyte activation relies on reprogramming of key metabolic pathways and the sufficient availability of nutrients like glucose and amino acids [1, 2]. Deficiency of the amino acid arginine is crucially involved in inflammation- and cancerassociated immunosuppression with profound impairment of T cell functions [3,4,5,6]. Arginine is metabolized to ornithine and urea by the enzyme arginase, expressed by different types of myeloid cells, such as alternatively activated macrophages, myeloid-derived suppressor cells (MDSC) [7], or conventional granulocytes [8]. Inhibition of arginase-expressing MDSC [7] or supplementation of arginine to T cells [6] leads to increased efficiency of antitumoral T cells
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
